Wolverine Trading’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-2,600
Closed -$286K 5593
2019
Q4
$286K Buy
+2,600
New +$267K ﹤0.01% 3653
2019
Q3
Sell
-5,500
Closed -$545K 5283
2019
Q2
$545K Buy
+5,500
New +$525K ﹤0.01% 2627
2019
Q1
Sell
-2,700
Closed -$240K 5620
2018
Q4
$240K Buy
+2,700
New +$273K ﹤0.01% 3478
2018
Q1
Sell
-3,300
Closed -$301K 6124
2017
Q4
$301K Buy
+3,300
New +$275K ﹤0.01% 3628
2016
Q4
Sell
-4,600
Closed -$254K 5427
2016
Q3
$254K Sell
4,600
-4,500
-49% -$221K ﹤0.01% 3474
2016
Q2
$379K Buy
+9,100
New +$419K ﹤0.01% 2536

Other funds holding PRAH

Wolverine Trading's PRAH Position: Q1 2018 in Review

Wolverine Trading sold out of PRA Health Sciences, Inc. (PRAH) in Q1 2018, closing a stake of 3,155 shares — an estimated $287K sold.

Wolverine Trading first reported a position in PRAH in Q4 2017 and held it in 1 quarter. The position peaked at $287K in Q4 2017. 278 funds tracked by Wall St. Rank hold PRAH as of Q1 2018.

  • Wolverine Trading reported no remaining PRA Health Sciences, Inc. position as of Q1 2018 after selling out during the quarter.
  • Wolverine Trading sold 3,155 PRA Health Sciences, Inc. shares in Q1 2018, an estimated $287K.
  • Wolverine Trading first reported a position in PRA Health Sciences, Inc. in Q4 2017 and held it in 1 quarter.
  • Wolverine Trading's PRA Health Sciences, Inc. position peaked at $287K in Q4 2017.
  • 278 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q1 2018.

Based on Wolverine Trading's 13F filing for Q1 2018, filed 15 May 2018.